- Home
- PCVX vs LEU Comparison
PCVX vs LEU Comparison
Compare PCVX & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- LEU
- Stock Information
- Founded
- PCVX 2013
- LEU 1998
- Country
- PCVX United States
- LEU United States
- Employees
- PCVX N/A
- LEU N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- PCVX Health Care
- LEU Industrials
- Exchange
- PCVX Nasdaq
- LEU Nasdaq
- Market Cap
- PCVX 6.0B
- LEU 6.9B
- IPO Year
- PCVX 2020
- LEU 1998
- Fundamental
- Price
- PCVX $49.03
- LEU $247.89
- Analyst Decision
- PCVX Strong Buy
- LEU Buy
- Analyst Count
- PCVX 7
- LEU 10
- Target Price
- PCVX $101.67
- LEU $219.00
- AVG Volume (30 Days)
- PCVX 1.3M
- LEU 1.4M
- Earning Date
- PCVX 11-04-2025
- LEU 11-05-2025
- Dividend Yield
- PCVX N/A
- LEU N/A
- EPS Growth
- PCVX N/A
- LEU 31.25
- EPS
- PCVX N/A
- LEU 6.17
- Revenue
- PCVX N/A
- LEU $454,100,000.00
- Revenue This Year
- PCVX N/A
- LEU $5.50
- Revenue Next Year
- PCVX N/A
- LEU $8.59
- P/E Ratio
- PCVX N/A
- LEU $40.52
- Revenue Growth
- PCVX N/A
- LEU 15.25
- 52 Week Low
- PCVX $27.66
- LEU $49.40
- 52 Week High
- PCVX $98.17
- LEU $464.25
- Technical
- Relative Strength Index (RSI)
- PCVX 69.14
- LEU 34.62
- Support Level
- PCVX $40.14
- LEU $254.01
- Resistance Level
- PCVX $45.90
- LEU $283.89
- Average True Range (ATR)
- PCVX 2.30
- LEU 28.69
- MACD
- PCVX 0.26
- LEU -13.61
- Stochastic Oscillator
- PCVX 91.15
- LEU 11.13
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.